Assessment of the hepatic cytochrome P450 reductase null mouse model: Effect on clearance and exposure of docetaxel, midazolam, nelfinavir and theophylline

被引：0
|
作者：
Boggs, Jason W. [1 ]
Choo, Edna F. [1 ]
Dornier, Anna [1 ]
Reich, Michael [2 ]
Hop, Cornelis [1 ]
机构：
[1] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA
[2] Genentech Inc, Vivo Studies, San Francisco, CA 94080 USA
来源：
DRUG METABOLISM REVIEWS | 2009年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
121
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] The Hepatic cytochrome P450 reductase null (HRN) mouse model as a tool to study xenobiotic metabolism
    Arlt, V. M.
    Henderson, C. J.
    Wolf, C. R.
    Phillips, D. H.
    Stiborova, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 83 - 83
  • [2] The Hepatic Cytochrome P450 reductase null (HRN) mouse model as a tool to study carcinogen metabolism
    Arlt, Volker M.
    MUTAGENESIS, 2009, 24 (06) : 524 - 524
  • [3] The Hepatic Cytochrome P450 reductase null (HRN) mouse model as a tool to study xenobiotic metabolism
    Arlt, V. M.
    FEBS JOURNAL, 2009, 276 : 19 - 19
  • [4] Role of hepatic cytochrome P450s in the pharmacokinetics and toxicity of cyclophosphamide: Studies with the hepatic cytochrome P450 reductase null mouse
    Pass, GJ
    Carrie, D
    Boylan, N
    Lorimore, S
    Wright, E
    Houston, B
    Henderson, CJ
    Wolf, CR
    CANCER RESEARCH, 2005, 65 (10) : 4211 - 4217
  • [5] Hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity
    Henderson, C. J.
    Pass, G. J.
    Finn, R.
    Wolf, C. R.
    TOXICOLOGY LETTERS, 2005, 158 : S15 - S15
  • [6] The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity
    Henderson, CJ
    Pass, GJ
    Wolf, CR
    TOXICOLOGY LETTERS, 2006, 162 (01) : 111 - 117
  • [7] Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine:: Studies with the hepatic NADPH:: Cytochrome P450 reductase null mouse
    Stiborova, Marie
    Arlt, Volker M.
    Henderson, Colin J.
    Wolf, C. Roland
    Kotrbova, Vera
    Moserova, Michaela
    Hudecek, Jiri
    Phillips, David H.
    Frei, Eva
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 226 (03) : 318 - 327
  • [8] Exposure to benzo[A]pyrene in the hepatic cytochrome p450 oxidoreductase null mouse: Detoxification by hepatic cytochrome p450 is more important than metabolic activation
    Arit, V. M.
    Stiborova, M.
    Henderson, C. J.
    Thieniann, M.
    Frei, E.
    Singh, R.
    da Costa, G. G.
    Schmitz, O. J.
    Farmer, P. B.
    Wolf, C. R.
    Phillips, D. H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 73 - 73
  • [9] Studies with the hepatic NADPH:: Cytochrome P450 reductase null mouse reveal the role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine
    Stiborova, M.
    Arlt, V. M.
    Phillips, D. H.
    Henderson, C. J.
    Wolf, C. R.
    Hodek, P.
    Hudecek, J.
    Frei, E.
    PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON CYTOCHROMES P450 - BIOCHEMISTRY, BIOPHYSICS AND FUNCTIONAL GENOMICS, 2007, : 129 - +
  • [10] Exposure to benzo(a) pyrene in the hepatic cytochrome P450 oxidoreductase (POR) null mouse:: detoxification by hepatic cytochrome P450 is more important than metabolic activation
    Arlt, Volker M.
    Stiborova, Marie
    Henderson, Colin J.
    Thiemann, Markus
    Frei, Eva
    Aimova, Dagmar
    Singh, Rajinder
    da Costa, Goncalo Gamboa
    Schmitz, Oliver J.
    Farmer, Peter B.
    Wolf, C. Roland
    Phillips, David H.
    MUTAGENESIS, 2007, 22 (06) : 439 - 439
12345